'Present address (for correspondence): 11398 High Hay Drive, Columbia, MD 21044, USA l\imors induced in -2000 F344 rats by a number of carcinogenic iV-nitroso compounds have been examined for their propensity to metastasize. The objective was to discover relations between the structure of the carcinogen, the tumor induced and the proportion of tumors that formed metastases. Treatments consisted of multiple doses of one of 16 nitrosamines or 19 alkylnitrosoureas, which were administered in drinking water, by gavage or by the intravesicular route. Male and female rats were included. Most of the carcinogens were mutagens in bacteria, but some were not; this had no bearing on the tendency of induced tumors to metastasize, nor did the extent of alkylation of DNA produced in vivo. Fewer malignant tumors appeared in the rats treated with nitrosamines than with alkylnitrosoureas, but more than twice as many of the former metastasized; many were carcinomas or hemangiosarcomas of the liver, of which very few were induced by alkylnitrosoureas. Tumors of the liver, lung, mammary gland and forestomach metastasized most commonly, whereas those of the esophagus, nasal mucosa, Zymbal gland, kidney mesenchyme, thyroid, urinary bladder and mesotheliomas seldom formed metastases; none of the tumors of the brain or intestines metastasized; no differences between males and females were noted. Some rare tumors, osteosarcomas and thymus lymphomas, metastasized frequently. The lungs and lymph nodes were the most common sites for metastases, but less frequently liver, heart, kidney, adrenal gland, omentum, peritoneum, esophagus and pancreas were involved. Higher doses were associated with greater numbers of metastasizing tumors among mutagenic or non-mutagenic carcinogens, as has been reported elsewhere. It appears that directly alkylating alkylnitrosoureas are no more likely (and probably less likely) to induce tumors with metastatic properties than are nitrosamines that require metabolic activation to form reactive proximate carcinogens.
Introduction
In humans, tumors that metastasize are frequently the most debilitating and the most difficult to treat, so that they frequently cause death. Considerable effort, therefore, has been given to investigations of the biological factors influencing the metastatic potential of tumors, for example the work of I.J.Fidler (1). Much experimental work has been done with tumors that have arisen 'spontaneously' in animals or have been induced in a particular carcinogenic protocol, then transplanted, and progress has been made in understanding the biological properties of these tumors.
Experimental tumors, even of the same cellular origin, differ greatly in their tendency to metastasize, yet there seem to be few investigations of the relationship between the carcinogen treatment and the metastatic potential of rumors induced in animals. Long ago it was proposed that a considerable proportion of human tumors owes its origin to exposure to carcinogens, so studies of the carcinogen -metastasis relationship could provide insights into the dependence of metastasizing tumors on the environment (including diet, habits, occupational exposures, etc.)
Relationships were seen between the types and number of tumors induced and differences in chemical structure of the compounds (2) . The effects of variations in dose rate, total dose, routes of administration, gender, age and hormonal status of the animals on tumorigenesis were studied. Several of the experiments were dose-response studies in which there were no metastases and few tumors at the lower doses, but many at higher doses. Several of the compounds were not carcinogenic or induced benign tumors, or malignant ones towards the end of the lifespan, and these produced no metastases. In the early experiments metastases were not consistently recorded. For these reasons only the results of several recent experiments are considered in which 19 alkylnitrosoureas and 16 nitrosamines were administered to, respectively, 968 and 1012 rats, several under a variety of conditions of dose and mode of administration. Only those experiments in which a high proportion of the animals in a treatment group (usually of 12 or 20 rats) developed tumors (benign or malignant) are included in the analysis. The results are presented here for discussion of the implications of the patterns observed in relation to the chemical structure of the carcinogens.
Methods
From 1976 to 1992 a large number of experiments were conducted by this author at the Frederick Cancer Research Facility, in which -200 alkylating carcinogens (mostly Nnitroso compounds) were administered to >9000 F344 rats. The animals were bred at FCRF, raised and housed within a barrier and were quite uniform. They were fed Purina Autoclavable Laboratory Chow ad libitum. All of the experiments employed multiple treatments with small doses over many weeks, beginning at 7-10 weeks of age, rather than a single or a few large doses; the purpose was to minimize acute toxic effects of these very reactive agents, which might interfere with the evaluation of the effects of variations in chemical structure on carcinogenesis, which was a main objective of our studies. In almost all cases the animals were allowed to die naturally following the treatment (which was usually limited to 20, 30 or occasionally 50 weeks), or were killed when moribund, and all organs and tissues were examined for tumors. Tumor diagnoses, including metastases, were based on histopathology. The tumors ordinarily arose (or were observed) long after all trace of the carcinogen had vanished. The early age at death of animals with a tumor was an important WXyinsky criterion of the greater effectiveness of the carcinogen treatment on a group.
Carcinogens studied
The potencies of the N-nitroso compounds studied varied, although all induced tumors in a large proportion of rats following treatment with relatively low doses. The carcinogens included simple alkylating agents, such as nitrosodimethylamine, methylnitrosourea and ethylnitrosourea, as well as nitrosamines that undergo complex metabolism, such as nitrosobis-(2-oxopropyl)-amine (3) and methylnitroso-Af-octylamine (4), and some (e.g. nitrosodiethanolamine and nitrosomorpholine) that form very low levels of DNA adducts, if at all. It is widely believed that carcinogens, including JV-nitroso compounds, exert their action through the mutational effects of formation of DNA adducts of particular types, of which O 6 -guanine alkylation is the most studied (5) .
Sometimes a single compound induced different tumors in different conditions, depending on the dose and the mode of administration (6, 7) , and sometimes on the gender of the rats (8) . The common tumors induced in rats in this series of experiments are listed in Table I , together with the proportion that metastasized; tumors not so indicated were never observed to metastasize in this series of studies. The most common tumors that metastasized were hepatocellular carcinomas and hemangiosarcomas of the liver, and alveolar-bronchiolar (A/B) carcinomas of the lung. As has been pointed out previously (9, 10) , there are sharp differences between the spectrum of tumors induced in rats by nitrosamines and by alkylnitrosamides, principally alkylnitrosoureas. With few exceptions, most of the tumors seen were induced by one class or the other, not both; exceptions are lung tumors, liver tumors, bladder tumors and mesenchymal tumors of the kidney. The reason for the failure of alkylnitrosoureas to induce all of the tumors induced by nitrosamines is perplexing, since alkylnitrosoureas are direct-acting alkylating agents and they can-and do (11)-alkylate DNA in all organs in which measurements have been made. However, alkylnitrosoureas are, in general, less, not more, toxic than are nitrosamines (10) . In particular, it is strange that two tumors commonly induced by nitrosaminesthose in the esophagus and nasal mucosa of rats-are virtually never observed in rats treated with alkylnitrosoureas, although they alkylate the DNA of all tissues (11, 12) , suggesting that it is the metabolism of the nitrosamines that is responsible for the induction of tumors in those organs, not simply the availability of alkylating intermediates. Therefore, it seems that additional properties of the carcinogen are responsible for development of tumors in a particular organ, in addition to formation of adducts with DNA. It is not improbable that yet other properties or activities of the carcinogen lead to increased malignancy of the tumors induced and to the acquisition of metastatic potential by the tumor cells.
Metastasizing tumors
A relatively small proportion of the tumors induced did metastasize, even of those enumerated in Table I as metastasizing regularly. In some groups a large proportion of the tumors metastasized, in other groups few or none. In Table II are shown the number of compounds which induced the most common rumors and the proportion of those compounds that induced tumors that metastasized. There seemed to be no particular relation between the detection of metastases and the time of death of animals bearing those tumors, although the 676 possibility that the development of metastases accelerated death of those animals cannot be excluded. Neither was there a relation of gender to the tendency of tumors to metastasize, the numbers being similar in groups of either sex that were comparable.
By far the largest number of metastasizing tumors were liver hemangiosarcomas and hepatocellular carcinomas, almost all by treatment with nitrosamines. The hemangiosarcomas metastasized more frequently (Table I ) than the hepatocellular carcinomas. Four compounds in the set were responsible for most of the liver metastases found, nitrosodiethylamine, methylnitrosoethylamine, nitrosomorpholine and nitrosodiethanolamine. In some groups of rats treated with these compounds a majority of the liver tumors metastasized, sometimes both tumors in the same animal. When two dose levels were used, the frequency of metastasis of liver rumors was often virtually the same in both groups, but at the higher dose both primary tumors and metastases were found earlier. Similarly, a large proportion of lung tumors was induced and metastasized in groups of rats treated with two compounds, nitrosodimethylamine and nitrosobis-(2-oxopropyl)-amine, and then only in males, whereas the liver tumors showed this behavior equally well in males and females. Several lung tumors (and mammary tumors) metastasized to the liver.
In the case of all of the other tumors, with the possible exception of mammary adenocarcinomas in female rats treated with ethylnitrosourea, the frequency of metastases in any one group of animals was low. Therefore, no wide judgements can be made about them, other than the general ones already mentioned. There was no particular time constraint on the appearance of metastasizing tumors. For example, the earliest metastasizing hepatocellular carcinoma was found at 28 weeks and the latest at 115 weeks after the beginning of treatment of rats at 7 weeks of age; the earliest liver hemangiosarcoma was seen at week 22 and the latest at week 121; the earliest lung carcinoma was found at week 40 and the latest at week 82; the earliest mammary adenocarcinoma was found at week 23 and the latest at week 67. The time at which tumors arose is not known precisely because they were observed only when the animal died. Less common metastasizing tumors were often seen quite early in the lifespan of rats, before week 35, e.g. transitional cell carcinoma of the bladder, malignant lymphoma, mesenchymal tumor of the kidney, esophageal carcinoma, nasal mucosa carcinoma. Other metastasizing tumors were seen only relatively late in life, e.g Schwannomas, thyroid follicular cell tumors. But the times of appearance of most of the metastasizing tumors covered a wide range and seemed not to be related to the age of the animal, but more closely to the dose of carcinogen administered, as well as to the structure and activity of the particular carcinogen. "Compounds tested Nitrosamines: /V-nitroso-dimethylamine, diethylamine, methylethylamine, morpholine, methyl-n-hexylamine, methyl-n-octylamine, methyl-2-oxopropylamine, diethanolamine, methyl-2-hydroxypropylamine, methylamino-3-pyridyl-1 -butanone, methyl-/V^V-dimethylaminoethylamine, bis-(2-hydroxypropyl)amine, bis-<2-oxopTopyl)amine, (2-hydroxypropyl)-(2-oxopropyl)-amine, 2,6-dimethylmorpholine, bis-(2-oxopropyl)amine-<l4. Alkylnitrosoureas: A'-nitroso-methylurea, ethylurea, allylurea, n-butylurea, n-amylurea, 2-phenylethylurea, 2-oxopropylurea, diethylurea, dimethylurea, 2-hydroxypropylurea, 3-hydroxypropylurea, 2-methoxy-ethylurea, methyl-
No brain tumors metastasized and the only tumors of the nervous system that did were Schwannomas of the spinal cord or nerves: 3/35 tumors in males and 2/18 in females. Very few mesotheliomas of the tunica vaginalis or transitional cell carcinomas of the urinary bladder or carcinomas of the Zymbal gland metastasized, although many of these tumors were considered to cause death of the animals. To some extent the results are weighted towards females, because twice as many female rats were included in this analysis as males. In contrast to the tumors that metastasized so infrequently, the small number of thymus lymphomas and of erythroleukemias usually metastasized. The tumors in Table I were rarely seen in untreated or solvent-treated controls; tumors that are considered 'spontaneous' (13) were unaffected in time of appearance by treatment with carcinogens and, of them, only mononuclear cell leukemias metastasized regularly, and they are not considered in this analysis. Some very rare tumors in F344 rats that were probably related to the treatment also metastasized, but these are not included in Table I ; they included myelogenous leukemia, erythroleukemia, forestomach neurofibrosarcoma, ovary thecoma, carcinoma of the gingiva, bone marrow sarcoma and sebaceous carcinoma of the skin. Many other tumors were observed infrequently among rats of this set, but they seldom metastasized; they include endometrial stromal sarcomas, adenocarcinomas of the duodenum, ileum and jejunum, kidney tubular cell carcinomas, hemangiosarcomas of the spleen, adenocarcinomas of the glandular stomach, cholangiocellular carcinomas of the liver, osteosarcomas, carcinomas of the tongue, pharynx and buccal mucosa, carcinomas of the trachea, acinar cell carcinomas of the pancreas, clitoral gland carcinomas, adrenal cortex carcinomas, transitional cell carcinomas of the kidney pelvis, urethra and ureter and carcinomas of the skin (14) .
Nitrosamines and alkylnitrosoureas
Several patterns stand out from the accumulated results. One is the rarity with which two of the commonest tumors, those of the esophagus and nasal mucosa, metastasized (two of each). Another is the much smaller proportion of alkylnitrosoureainduced tumors that metastasized, compared with those induced by nitrosamines; for example, both classes of carcinogen induce lung tumors, but no more than two of these in any alkylnitrosourea treatment group metastasized, compared with as many as six in nitrosamine-treated groups; a small proportion of mammary adenocarcinomas metastasized in any of the groups treated with an alkylnitrosourea.
Although alkylnitrosoureas are potent direct-acting mutagens, their ability to alkylate DNA extensively does not appear to impart to the tumors induced those characteristics favoring metastasis. This seems an important consideration in view of the current belief that increased malignancy is due to acquisition of multiple genetic alterations, as in human colon cancer. There does not seem to be a relationship between the age of the rat and the appearance of metastatic tumors. The number of weeks after beginning of treatment at which animals died with tumors (i.e. weeks of observation) tended to be greater at lower doses, and fewer at higher doses. The metastatic tumors fit well into this pattern, and at higher doses a greater proportion of the tumors metastasized. In Table III are shown the principal tumors induced in rats in this series of experiments, with a sharp separation between those induced by nitrosamines and those induced by alkylnitrosoureas (excepting lung tumors and liver tumors which were induced by both types of carcinogen). However, very few of the lung tumors and almost none of the liver carcinomas induced by alkylnitrosoureas metastasized, whereas a reasonable proportion of those tumors induced by nitrosamines metastasized, the proportion being quite high in some particular groups. It is perhaps not coincidental that the alkylnitrosoureas are not very toxic, as measured by tissue damage (15) and showed virtually no toxic effects at the doses used in our experiments in the organs in which they induced tumors.
It is possible that special conditions are responsible for the great susceptibility of the rat esophagus and nasal mucosa to the action of carcinogenic nitrosamines, but not to alkylnitrosoureas (the hamster esophagus does not appear to be susceptible to any carcinogens; 14). Perhaps the same characteristics of the target cells are responsible for reducing the tendency to metastasize. The same is not true of the rat forestomach, which is quite susceptible to induction of squamous cell carcinomas by alkylnitrosoureas, and even more so by alkylnitrosocarbamates-but also by nitrosamines (5, 10) ; the forestomach tumors metastasized, whereas only two nasal mucosa tumors (in females) and two squamous cell carcinomas of the esophagus (one in females) metastasized.
The alkylnitrosoureas are direct-acting alkylating agents and give rise to a similar extent of DNA alkylation in a large number of organs, those in which tumors are induced and those in which tumors are not induced by these compounds. Also, on a molar basis, nitrosamines and alkylnitrosoureas which produce the same alkylating intermediate (assumed to be an alkyldiazonium ion) give rise to similar levels of DNA alkylation in many organs, including liver (16) . However, among the 392 male rats (of 720) and 552 female rats (of 1236) treated with alkylnitrosoureas there was only one hepatocellular carcinoma (of seven), in a male, that metastasized, although there were many liver adenomas; only one alkylnitrosourea, phenylethylnitrosourea, induced hemangiosarcomas of the liver in 83% of rats, and most metastasized (17) . In contrast, 7^72 alveolar/bronchiolar carcinomas induced by several alkylnitrosoureas metastasized, as did 13/165 mammary adenocarcinomas, which were the only tumors induced by alkylnitrosoureas that metastasized frequently.
In general, few tumors induced by alkylnitrosoureas metastasized. This could be related to low cellular toxicity of alkylnitrosoureas compared with nitrosamines, implying the coupling of metabolic products of nitrosamines with both toxicity and induction of metastatic properties in transformed cells. It cannot be assumed that these properties are produced by metabolic intermediates that are necessarily DNA-damaging alkylating agents, because many non-mutagenic carcinogens quite readily induce tumors that metastasize, e.g. in rats nitrosodiethanolamine and methapyrilene. Unfortunately, in the report summarizing the bioassays of almost 400 chemicals (many of which are not mutagenic) by the National Toxicology Program (18) , there is no accounting of metastasizing tumors; it will be necessary to examine the original test reports. In one of these (19) , it was reported that, of the tumors induced by 4,4'-thiodianiline (which is mutagenic), 34-52% of follicular carcinomas of the thyroid, 44% of adenocarcinomas of the uterus and 21% of hepatocellular carcinomas metastasized to the lungs in F344 rats; there were no reports of metastases in the results of bioassays of a number of other aromatic amines.
Dose effects
There is no doubt that increasing doses of a carcinogen lead to increasing numbers of tumors that metastasize and to the earlier occurrence of those metastases. Both effects are true of the mutagenic liver carcinogen nitrosomorpholine (20) . In this nitrosomorpholine dose-response study the proportion of liver hemangiosarcomas that metastasized was particularly high, 52-88% in the five groups that had them.
Tumors induced by non-mutagenic carcinogens also increasingly metastasized at higher doses. Examples are nitrosodiethanolamine and methapyrilene, which have been negative in a variety of bacterial and cellular assays for mutagenicity or cell transformation (21, 22) ; DNA adducts with methapyrilene have not been found in the most sensitive test (23) . As much as 100% of hepatocellular carcinomas induced in rats within 34 weeks by high doses of nitrosodiethanolamine metastasized (21) , but fewer at much lower doses (24); 55-65% of hepatocellular carcinomas induced by feeding 1000 p.p.m. of the antihistamine methapyrilene to rats for -1 year metastasized (22) , but again fewer at lower doses (25, 26) . Therefore, the additional characteristics disposing to metastasis in these cases cannot be due to carcinogen-induced mutagenic changes, and so they might not be in the case of mutagenic carcinogens either.
Of the hepatocellular carcinomas induced in rats by moderate doses of nitrosodiethanolamine, 30-40% metastasized (24) , although none of those induced by lower doses (27) . Similarly, nitrosomorpholine (which is a mutagenic carcinogen-but a cyclic nitrosamine from which adducts with DNA in vivo have not yet been identified but might be formed at very low levels) induced increasing numbers of more malignant liver tumors in groups of rats as the dose increased. This was the case for both hepatocellular carcinomas and hemangiosarcomas; the incidence of the latter rose to 100% (at 4 mg/week), but was zero at low doses (0.26 mg/week or less) at which some hepatocellular neoplasms appear. Metastases formed from both types of liver tumor, 7/16 hepatocellular carcinomas (44%) at the maximum, and 16/24 hemangiosarcomas (67%) at the maximum. In this group that received the highest dose of nitrosomorpholine (250 mg total in 25 weeks) the animals died rapidly thereafter and only 1/15 hepatocellular carcinomas metastasized. At this high dose rate nitrosomorpholine caused much liver toxicity, but not at lower dose rates at which a majority of liver hemangiosarcomas nevertheless metastasized. In this experiment (20) a large proportion of liver hemangiosarcomas in rats induced by nitrosomorpholine metastasized (52-88%), possibly due to the endothelial origin of the tumors.
Among both mutagenic and non-mutagenic carcinogens it appears that increasing doses are correlated with increased proportions of tumors that metastasize, particularly at high dose rates, implying that the higher doses add the factors causing neoplastically transformed cells to metastasize. If these added properties (including invasiveness) are not due to mutations, how are they brought about? That, of course, is the same question that can be asked about carcinogenesis in general, since higher doses of any carcinogen usually increase the number and malignancy of tumors it induces. Among the experiments evaluated here are several in which different doses of the same carcinogen were administered and, in those cases, there were more animals with more malignant tumors and more metastases at higher doses than at lower doses. Also, at the higher doses the metastasizing tumors (like all of the tumors induced) presumably arose and killed the animals at earlier times than at lower doses, another index of the induction of additional properties in the neoplastically transformed cells.
For example, 15/16 female rats treated with 2.5 mg of nitrosodiethylamine twice a week had liver carcinomas or hemangiosarcomas (seven had carcinomas, one had sarcomas, seven had both) and all died before week 32; six carcinomas and five sarcomas metastasized and in one animal both tumors metastasized. At half that dose, 1.25 mg of nitrosodiethylamine twice a week, most animals died between week 34 and 40 and 11/12 had liver tumors; 10 had hemangiosarcomas, of which five metastasized and five had carcinomas, of which only one metastasized. All of 16 male rats receiving 2.5 mg nitrosodiethylamine twice a week had /iver carcinomas, of which five metastasized; two rats also had liver hemangiosarcomas, both of which metastasized, and all animals died before week 44. The higher dose per unit body weight in the females seemed to be responsible for the larger number of metastasizing hemangiosarcomas. Nitrosodiethylamine administered intravesically to female rats was equally effective in inducing liver carcinomas in 10/11 rats, all dying before week 35, but only one carcinoma metastasized, together with 1/4 hemangiosarcomas of the liver (28) . The pharmacokinetics of distribution and metabolism of nitrosodiethylamine injected into the bladder appeared to reduce the additional effect of the carcinogen predisposing the liver tumors to metastasize.
Discussion
Metastasis of tumors induced by these carcinogens does not seem to increase the risk of death of animals, since those that died with metastases were not necessarily the earliest to die of a group, although when there were several in this category they tended to die earlier.
Just as it is impossible to know when a tumor in a living animal arises, so it is not possible to know when one metastasizes. It is convenient (although possibly incorrect) to assume that metastases of a given tumor cause death of the animal in a similar time, whatever the agent causing the tumor. In this scenario the metastasis once formed develops independently of the presence of the carcinogen.
While this survey has not answered the questions 'What causes metastasis of tumors induced by carcinogens and how and why do tumors form metastases?', some observations can be made that might lead to experimental investigations of the matter. In this animal system formation of metastases does not seem to increase the overall lethality of the tumors. So-called 'non-genotoxic' carcinogens tend to require higher doses to induce tumors than genotoxic carcinogens, but resemble the latter in that higher doses also produce more metastatic tumors. The proportion of malignant tumors that are metastatic is not notably greater when induced by genotoxic carcinogens than by non-genotoxic carcinogens. Therefore, the direct induction of" mutations is not a requirement of a carcinogen to confer metastatic potential on the tumors it induces.
A majority of the 16 nitrosamines and 18 alkylnitrosoureas considered here induced some tumors that metastasized. But they differed considerably in the type of metastasizing tumor they induced and in the proportion of animals in which they appeared (i.e. their potency in inducing tumors that metastasized). By the latter criterion the nitrosamines were more effective than the alkylnitrosoureas (Table I) . More than 200 metastasizing tumors were induced by nitrosamines, compared with <70 by alkylnitrosoureas, notwithstanding that the number of tumors induced by the two classes of carcinogen was similar. In this survey the larger number of female rats with metastasizing tumors induced by nitrosamines is mainly due to the impact of a large dose-response study with nitrosomorpholine which is included. Nevertheless, there is a strong impression that nitrosamines had a greater potential for inducing metastases than did alkylnitrosoureas. This impression is tempered somewhat by the scarcity in the results of tumors that are induced equally well by nitrosamines and by alkylnitrosoureas, these being limited to alveolar-bronchiolar carcinomas of the lung, follicular cell tumors of the thyroid and mesenchymal tumors of the kidney. The lesser metastasis-inducing activity of the alkylnitrosoureas must be partly a function of the structural characteristics of these molecules that enables them to 'target' particular organs and leave others unaffected, although they alkylate DNA in all organs and tissues that have been examined (11). It is also probably related to the lesser toxicity of alkylnitrosoureas compared with nitrosamines (10) and this, in turn, seems to be related to metabolism of the nitrosamines into toxic products that are not formed from alkylnitrosoureas (i.e. not alkyldiazonium ions). The toxic products formed from nitrosamines have usually not been identified, but might include alkylnitrosoformamides (29) , which are more toxic than the more widely known oc-hydroxynitrosamines (30) . It is more difficult to understand this aspect of nitrosamine carcinogenesis in the case of cyclic nitrosamines. of which only two are represented in this set of compounds. The corresponding product to an alkylnitrosoformamide is a nitrosolactam, and those few that are isolable are toxic, but unstable (e.g. nitrosopyrrolidone).
Conclusions
This review sheds some light on possible mechanisms of induction of metastatic properties in a malignant tumor. Most of the tumors induced in this series of experiments were, of course, benign and there was frequently in a treatment group a gradation from benign to malignant to metastasizing tumors; the latter became more frequent at the higher doses of carcinogen. Since even the highest doses of an alkylnitrosourea, e.g. ethylnitrosourea, did not induce liver tumors although it was a direct-acting alkylating agent giving rise to many other tumors in rats, it cannot be supposed that additional alkylated lesions in DNA produced by high doses of the analogous dialkylnitrosamine (in this case ethylation by nitrosodiethylamine) can be responsible for the induction of so many readily metastasizing liver tumors. Indeed, the failure to induce primary liver tumors by most, but not all (31), alkylnitrosoureas cannot be ascribed as it was (32) to ready repair of the alkylated C^-guanine lesion in DNA by the alkylguanine-DNA-alkyltransferase, following the finding that inhibition of this 'enzyme' by administration of C^-benzylguanine prior to treatment with ethylnitrosourea or methylnitrosourea failed to cause induction of any liver tumors (33) . It is probable, therefore, that those effects of carcinogen treatment that lead to expression in malignant tumors of the metastatic phenotype are not those due to alkylation of DNA, but are of a different type acting at other loci in the cell. There is little indication from present knowledge of what these other effects might be, or why metastasis of certain tumors is favored, nor why most of the metastases we observed were to the lungs or lymph nodes in the rat, and seldom to other organs.
Questions raised by this analysis include (i) why do only some of the chemically similar alkylating carcinogens induce tumors that metastasize; (ii) why are metastasizing liver tumors (hepatocellular and endothelial) so favored by nitrosamines, but not by alkylnitrosoureas; (iii) why does a given carcinogen induce metastasizing liver tumors in rats, but non-metastasizing tumors of other organs (e.g. lung), and vice versa in the case of another carcinogen; (iv) what can be the effect of increasing dose in increasing the proportion of tumors that metastasize, without necessarily increasing the incidence of primary tumors; (v) why in some groups do hepatocellular tumors metastasize as frequently as hemangiosarcomas of the liver, although the latter arise from cells lining the blood vessels and can easily enter the bloodstream?
An answer to all of these questions might lie in a separation between the mechanism of induction of neoplastic transformation, and the mechanism of induction of other properties of me consequent tumor cells, including invasiveness and metastasis. These might depend on properties manifest only at higher doses of carcinogen, perhaps allied with toxicity, but presently unexplained.
